Observational studyBMC infectious diseases2026

Risk factors for adverse events associated with trimethoprim-sulfamethoxazole treatment for Pneumocystis pneumonia in non-human immunodeficiency virus-infected patients: a multicenter, retrospective, observational cohort study.

Reina Idemitsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.